RRP9: A Key Player in RNA Processing and Cellular Regulation (G9136)

Target Name: RRP9

NCBI ID: G9136

RRP9

RRP9: A Key Player in RNA Processing and Cellular Regulation

Ribosomal RNA processing 9 (RRP9) is a protein that is expressed in all eukaryotic cells and is involved in the processing of ribosomal RNA (rRNA) into smaller nuclear RNA (snRNA) and finally exons. It is a key player in the regulation of gene expression and has been implicated in a wide range of cellular processes, including cell growth, differentiation, and metabolism.

RRP9 is a 26kDa protein that is composed of a unique nucleotide-binding domain and a transmembrane region. The nucleotide-binding domain is responsible for binding to U3 small nucleolar RNA (SNRNA), which is a protein that plays a critical role in the processing of rRNA into snRNA. The transmembrane region is responsible for the protein's localization to the endoplasmic reticulum (ER) and for its ability to interact with various cellular signaling pathways.

RRP9 has been shown to play a critical role in the regulation of gene expression and has been implicated in a wide range of cellular processes. For example, studies have shown that RRP9 plays a role in the regulation of cell growth and that it is involved in the regulation of cell apoptosis. Additionally, RRP9 has been shown to be involved in the regulation of cellular metabolism and that it is involved in the metabolism of essential amino acids.

RRP9 is also a potential drug target and has been shown to be a promising biomarker for various diseases. For example, studies have shown that RRP9 is involved in the regulation of cancer cell growth and that it is a potential therapeutic target for cancer. Additionally, RRP9 has been shown to be involved in the regulation of neurodegenerative diseases and has been shown to play a role in the treatment of various neurological disorders.

In conclusion, RRP9 is a protein that is involved in the regulation of gene expression and has been shown to play a critical role in a wide range of cellular processes. It is a potential drug target and has been shown to be involved in the regulation of various diseases. Further research is needed to fully understand the role of RRP9 in cellular processes and to develop new therapeutic approaches for the treatment of diseases associated with its dysfunction.

Protein Name: Ribosomal RNA Processing 9, U3 Small Nucleolar RNA Binding Protein

Functions: Component of a nucleolar small nuclear ribonucleoprotein particle (snoRNP) thought to participate in the processing and modification of pre-ribosomal RNA (pre-rRNA) (PubMed:26867678). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797)

The "RRP9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RRP9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets